588 related articles for article (PubMed ID: 26644378)
61. Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA).
de Miranda AS; Lacerda-Queiroz N; de Carvalho Vilela M; Rodrigues DH; Rachid MA; Quevedo J; Teixeira AL
Neurosci Lett; 2011 Mar; 491(3):202-6. PubMed ID: 21256928
[TBL] [Abstract][Full Text] [Related]
62. Heme dampens T-cell sequestration by modulating glial cell responses during rodent cerebral malaria.
Dalko E; Genete D; Auger F; Dovergne C; Lambert C; Herbert F; Cazenave PA; Roland J; Pied S
Brain Behav Immun; 2016 Nov; 58():280-290. PubMed ID: 27477919
[TBL] [Abstract][Full Text] [Related]
63. Using a new three-dimensional CUBIC tissue-clearing method to examine the brain during experimental cerebral malaria.
Matsuo-Dapaah J; Lee MSJ; Ishii KJ; Tainaka K; Coban C
Int Immunol; 2021 Oct; 33(11):587-594. PubMed ID: 34455438
[TBL] [Abstract][Full Text] [Related]
64. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
65. Cerebral Malaria Is Regulated by Host-Mediated Changes in
Cimperman CK; Pena M; Gokcek SM; Theall BP; Patel MV; Sharma A; Qi C; Sturdevant D; Miller LH; Collins PL; Pierce SK; Akkaya M
mBio; 2023 Apr; 14(2):e0339122. PubMed ID: 36852995
[TBL] [Abstract][Full Text] [Related]
66. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
67. Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice.
Sarfo BY; Wilson NO; Bond VC; Stiles JK
Malar J; 2011 Mar; 10():69. PubMed ID: 21439091
[TBL] [Abstract][Full Text] [Related]
68. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.
Torre S; Langlais D; Gros P
Mamm Genome; 2018 Aug; 29(7-8):488-506. PubMed ID: 29922917
[TBL] [Abstract][Full Text] [Related]
69. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.
Beghdadi W; Porcherie A; Schneider BS; Dubayle D; Peronet R; Huerre M; Watanabe T; Ohtsu H; Louis J; Mécheri S
J Exp Med; 2008 Feb; 205(2):395-408. PubMed ID: 18227221
[TBL] [Abstract][Full Text] [Related]
71. High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology.
Haque A; Best SE; Amante FH; Ammerdorffer A; de Labastida F; Pereira T; Ramm GA; Engwerda CR
Infect Immun; 2011 May; 79(5):1882-8. PubMed ID: 21343349
[TBL] [Abstract][Full Text] [Related]
72. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
73. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection.
Nie CQ; Bernard NJ; Norman MU; Amante FH; Lundie RJ; Crabb BS; Heath WR; Engwerda CR; Hickey MJ; Schofield L; Hansen DS
PLoS Pathog; 2009 Apr; 5(4):e1000369. PubMed ID: 19343215
[TBL] [Abstract][Full Text] [Related]
74. Comparison of CD8
Barrera V; Haley MJ; Strangward P; Attree E; Kamiza S; Seydel KB; Taylor TE; Milner DA; Craig AG; Couper KN
Front Immunol; 2019; 10():1747. PubMed ID: 31396236
[TBL] [Abstract][Full Text] [Related]
75. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.
Edwards CL; Best SE; Gun SY; Claser C; James KR; de Oca MM; Sebina I; Rivera Fde L; Amante FH; Hertzog PJ; Engwerda CR; Renia L; Haque A
Eur J Immunol; 2015 Jan; 45(1):130-41. PubMed ID: 25319247
[TBL] [Abstract][Full Text] [Related]
76. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
77. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria.
Vigário AM; Gorgette O; Dujardin HC; Cruz T; Cazenave PA; Six A; Bandeira A; Pied S
Int J Parasitol; 2007 Jul; 37(8-9):963-73. PubMed ID: 17350019
[TBL] [Abstract][Full Text] [Related]
78. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Burrack KS; Huggins MA; Taras E; Dougherty P; Henzler CM; Yang R; Alter S; Jeng EK; Wong HC; Felices M; Cichocki F; Miller JS; Hart GT; Johnson AJ; Jameson SC; Hamilton SE
Immunity; 2018 Apr; 48(4):760-772.e4. PubMed ID: 29625893
[TBL] [Abstract][Full Text] [Related]
79. Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria.
Bucher K; Dietz K; Lackner P; Pasche B; Fendel R; Mordmüller B; Ben-Smith A; Hoffmann WH
Int J Parasitol; 2011 Jan; 41(1):21-31. PubMed ID: 20708623
[TBL] [Abstract][Full Text] [Related]
80. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.
Belnoue E; Kayibanda M; Vigario AM; Deschemin JC; van Rooijen N; Viguier M; Snounou G; Rénia L
J Immunol; 2002 Dec; 169(11):6369-75. PubMed ID: 12444144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
